Income Taxes (Tables)

12 Months Ended

Dec. 31, 2024

Income Tax Disclosure [Abstract]

Schedule of (Income) Loss Before Income Taxes

The following table presents the loss (income) before income taxes for the periods presented (in thousands): 

	For the Year Ended December 31,
	2024		2023		2022
Loss (income) attributable to common stockholders	$	2,872,984	$	1,617,188	$	(175,668)
Loss attributable to noncontrolling interest and redeemable noncontrolling interests	1,509,050		1,078,344		1,023,022
Loss before income taxes	$	4,382,034	$	2,695,532	$	847,354

Schedule of Income Tax (Benefit) Provision

The income tax (benefit) provision consists of the following (in thousands):

	For the Year Ended December 31,
	2024		2023		2022
Current
Federal	$	—	$	—	$	—
State	—		—		—
Foreign	—		—		—
Total current (benefit) expense	—		—		—
Deferred
Federal	(25,833)		(23,583)		1,460
State	(984)		10,892		831
Foreign	—		—		—
Total deferred (benefit) provision	(26,817)		(12,691)		2,291
Total	$	(26,817)	$	(12,691)	$	2,291

Schedule of Reconciliation of The Statutory Federal Rate

The following table represents a reconciliation of the statutory federal rate and the Company’s effective tax rate for the periods presented:

	For the Year Ended December 31,
	2024		2023		2022
Tax provision (benefit) at federal statutory rate	(21.00)	%	(21.00)	%	(21.00)	%
State income taxes, net of federal benefit	0.06		(1.11)		3.42
Foreign provision, net of federal benefit	(0.71)		—		—
Effect of noncontrolling and redeemable noncontrolling interests	7.23		8.40		25.35
Stock-based compensation	0.27		0.46		1.03
Tax credits	(1.78)		(0.63)		(1.42)
Effect of valuation allowance	(0.16)		4.06		(7.47)
Goodwill impairment	14.96		9.02		—
Other	0.52		0.33		0.36
Total	(0.61)	%	(0.47)	%	0.27	%

Schedule of Deferred Tax Assets and Liabilities

The following table represents the components of the Company’s deferred tax assets and liabilities for the periods presented (in thousands):

	December 31,
	2024		2023
Deferred tax assets
Accruals and prepaids	$	48,019	$	47,922
Deferred revenue	149,928		81,692
Net operating loss carryforwards	835,420		788,507
Stock-based compensation	16,962		12,309
Investment tax and other credits	168,623		122,317
Interest expense	188,016		125,332
UNICAP costs	73,180		110,656
Total deferred tax assets	1,480,148		1,288,735
Less: Valuation allowance	(165,000)		(174,328)
Gross deferred tax assets	1,315,148		1,114,407
Deferred tax liabilities
Interest rate derivatives	27,134		16,945
Capitalized costs to obtain a contract	486,978		375,226
Fixed asset depreciation and amortization	696,755		580,569
Deferred tax on investment in partnerships	242,221		264,537
Gross deferred tax liabilities	1,453,088		1,237,277
Net deferred tax liabilities	$	(137,940)	$	(122,870)

Schedule of Tax Years that Remain Open and Subject to Examination by the Tax Authorities

The following table summarizes the tax years that remain open and subject to examination by the tax authorities in the most significant jurisdictions in which the Company operates:

	Tax Years
U.S. Federal	2020-2024
State	2019-2024
Foreign	2019-2024